DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Exisulind
Exisulind
Practice Parameters for the Treatment of Patients with Dominantly Inherited Colorectal Cancer
Current Advances of Nitric Oxide in Cancer and Anticancer Therapeutics
New Drugs Are Not Enough‑Drug Repositioning in Oncology: an Update
Antiproliferative and Proapoptotic Activities of Anthocyanin and Anthocyanidin Extracts from Blueberry Fruits on B16-F10 Melanoma Cells
Modifications to the Harmonized Tariff Schedule of the United States To
Annexes to the Annual Report of the European Medicines Agency 2014
The Old, the New, and the Future
Sildenafil Increases Chemotherapeutic Efficacy of Doxorubicin in Prostate
Low-Dose Anti-Inflammatory Combinatorial Therapy Reduced Cancer Stem Cell Formation in Patient-Derived Preclinical Models for Tumour Relapse Prevention
I Regulations
(12) Patent Application Publication (10) Pub. No.: US 2009/0226431 A1 Habib (43) Pub
Customs Tariff - Schedule
Recommendations for Scientific Research & Prevention Program (SRPP) Committees
Wo 2008/127291 A2
(12) United States Patent (10) Patent No.: US 6,555,547 B1 Pamukcu Et Al
Analytics for Improved Cancer Screening and Treatment John
(12) Patent Application Publication (10) Pub. No.: US 2015/0150995 A1 Taft, III Et Al
NIH Public Access Author Manuscript Cancer
Top View
View Will Be Helpful As a Foundation to Development and Design of Novel Tubulin Inhibitors Targeting Colchicine Site
No Additional Benefit of Adding Ifosfamide to Docetaxel in Castration-Resistant Metastatic Prostate Cancer
United States Patent (10) Patent No.: US 9,605,003 B2 Castro Et Al
Orphan Drug Designations and Approvals List As of 12-02-2013 Governs January 1, 2014
A ABT-751, 178 Adjuvant Chemotherapy Bladder Cancer, 115
Sildenafil Potentiates the Therapeutic Efficacy of Docetaxel in Advanced
Chemical Structure-Related Drug-Like Criteria of Global Approved Drugs
Exisulind and Related Compounds Inhibit Expression and Function of the Androgen Receptor in Human Prostate Cancer Cells
Sensitizes Prostate Cancer Cells to Doxorubicin-Mediated Apoptosis Through CD95
(IPA) of GFP (+) Versus Mock Organoid Subpopulations
Pharmaabkommen A1 E
Targeting the Canonical WNT/Β-Catenin Pathway in Cancer Treatment Using Non-Steroidal Anti-Inflammatory Drugs
Customs Tariff - Schedule Xxi - 1
Nimesulide and Celecoxib Inhibits Multiple Oncogenic Pathways In
5965.Full-Text.Pdf
2004 Annual Report OSI Pharmaceuticals, Inc. 2004 Annual
(12) Patent Application Publication (10) Pub. No.: US 2010/0226943 A1 Brennan Et Al
Medical Use of Spla2 Hydrolysable Liposomes